Current Radiopharmaceuticals

Editor-in-Chief

Andrea Ciarmiello
Chief of Nuclear Medicine Unit and Imaging Department
S. Andrea Hospital
La Spezia
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 3, July

Editorial [Hot Topic: Targeted Alpha Therapy – Part I (Guest Editor: Jorgen Elgqvist)]

Volume:4   Issue: 3
Pp: 176-176
Jorgen Elgqvist
DOI: 10.2174/1874471011104030176
Published on: 01 March, 2012

Astatine-211: Production and Availability

Volume:4   Issue: 3
Pp: 177-185
Michael R. Zalutsky and Marek Pruszynski
DOI: 10.2174/1874471011104030177
Published on: 01 March, 2012

The ARRONAX Project

Volume:4   Issue: 3
Pp: 186-196
Ferid Haddad, Jacques Barbet and Jean-Francois Chatal
DOI: 10.2174/1874471011104030186
Published on: 01 March, 2012

Protein Targeting Constructs in Alpha Therapy

Volume:4   Issue: 3
Pp: 197-213
Tove Olafsen, Jorgen Elgqvist and Anna M. Wu
DOI: 10.2174/1874471011104030197
Published on: 01 March, 2012

Chemical and Radiochemical Considerations in Radiolabeling with α-Emitting Radionuclides

Volume:4   Issue: 3
Pp: 214-247
D. Scott Wilbur
DOI: 10.2174/1874471011104030214
Published on: 01 March, 2012

Pretargeted Radioimmunotherapy with α-Particle Emitting Radionuclides

Volume:4   Issue: 3
Pp: 248-260
Sture Lindegren and Sofia H.L. Frost
DOI: 10.2174/1874471011104030248
Published on: 01 March, 2012

Modelling and Dosimetry for Alpha-Particle Therapy

Volume:4   Issue: 3
Pp: 261-265
George Sgouros, Robert F. Hobbs and Hong Song
DOI: 10.2174/1874471011104030261
Published on: 01 March, 2012

Alpha-Particle Microdosimetry

Volume:4   Issue: 3
Pp: 266-280
Nicolas Chouin and Manuel Bardies
DOI: 10.2174/1874471011104030266
Published on: 01 March, 2012